TPD

CT-01 compounds induce degradation of GSPT1, SALL4 and another as yet undisclosed neo-substrateThe unique degradation profile supports the strong competitive potential of the programCompelling pre-clinical data generated demonstrating HCC…

WROCLAW, Poland, April 11, 2022 (GLOBE NEWSWIRE) -- Captor Therapeutics S.A. (WSE:CTX), a biopharmaceutical company focused on the development of targeted protein degradation (TPD) drugs for cancer and autoimmune diseases, today…

Reading Time: 3 minutes  The global betting and predictions market is expected to grow to over $92 billion by 2023 as new players, nations, and states embrace the industry. Huge economies such as the U.S. have long…